Deferasirox (Exjade\uae) 6530 Mg/Kg/Day is effective in reducing iron burden in thalassemia major patients previously chelated with monotherapy or combination therapy

Authors
Publication date
1 November 2009
Publisher
W.B.Saunders

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    AIR Universita degli studi di Milano

    redirect
    oaioai:air.unimi.it:2434/72292
    Last time updated on 06/03/2019